Procurement Summary
Country : USA
Summary : AMBR15 and AMBR250 Single Use Bioreactors Operational Parts and Components.
Deadline : 28 Aug 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 106191351
Document Ref. No. : 75F40124Q00499
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Solicitation Number:75F40124Q00499
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024.
THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE
SOLICITATION WILL NOT BE ISSUED.
The solicitation number for this acquisition is 75F40124Q00499 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 334516 and the Small Business Size Standard is 1000 employees. This will be awarded as Firm-Fixed Price and completed as a full and open competition. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary.
The U.S. Food and Drug Administration (FDA) requires operational parts and components for single-use bioreactors (Sartorius AMBR15 and AMBR250)
BACKGROUND AND OVERVIEW
OPQR currently owns and operates a Sartorius ambr15 48-way microbioreactor system (Generation 1; Serial No. R3-0147) and an ambr250 modular system that enables parallel automated operation of eight (8) single-use mini-bioreactors (Serial No. 44a250m-CM1010). To date, these two systems have provided several significant benefits to OPQR research by reducing time, labor, and raw materials necessary compared to the operation of larger scale bioreactors that are manually assembled, cleaned, and sanitized. In addition to convenience, both systems greatly improve experimental throughput and robustness. Several OPQR projects investigating the impacts of manufacturing process changes on reco...
Active Contract Opportunity
Notice ID : 75F40124Q00499
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : FOOD AND DRUG ADMINISTRATION
Office: FDA OFFICE OF ACQ GRANT SVCS
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 22, 2024 02:26 pm EDT
Original Date Offers Due: Aug 28, 2024 10:00 am EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 12, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
Place of Performance: Silver Spring, MD 20993 USA
Documents
Tender Notice
RFQ-CDER-2024-123841-08202024.pdf